Claims
- 1. A complex of protein-protein interaction as defined in columns 1 and 3 in Table 2.
- 2. A complex of polynucleotides as defined in Table 1 encoding for the polypeptides.
- 3. A recombinant host cell expressing the interacting polypeptides of said complex of protein-protein interaction of claim 1.
- 4. A method for selecting a modulating compound comprising:
(a) cultivating a recombinant host cell on a selective medium containing a modulating compound and a reporter gene the expression of which is toxic for said recombinant host cell wherein said recombinant host cell is transformed with two vectors:
(i) wherein said first vector comprises a polynucleotide encoding a first hybrid polypeptide and a DNA bonding domain; (ii) wherein said second vector comprises a polynucleotide encoding a second hybrid polypeptide and an activating domain that activates said toxic reporter gene when the first and second hybrid polypeptides interact; and (b) selecting said modulating compound which inhibits the growth of said recombinant host cell.
- 5. A modulating compound obtained from the method of claim 4.
- 6. A pharmaceutical composition comprising the modulating compound of claim 5 and a pharmaceutically acceptable carrier.
- 7. A record comprising all or part of the data set forth in Tables 1 and 2.
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 60/259,377, filed Jan. 2, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60259377 |
Jan 2001 |
US |